Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

1. Peeters, M.
2. Oliner, K.S.
3. Price, T.J.
4. Cervantes, A.
5. Sobrero, A.F.
6. Ducreux, M.
7. Hotko, Y.
8. André, T.
9. Chan, E.
10. Lordick, F.
11. Punt, C.J.A.
12. Strickland, A.H.
13. Wilson, G.
14. Ciuleanu, T.E.
15. Roman, L.
16. Van Cutsem, E.
17. He, P.
18. Yu, H.
19. Koukakis, R.
20. Terwey, J.-H.
21. Jung, A.S.
22. Sidhu, R.
23. Patterson, S.D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/1078-0432.CCR-15-0526 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus